#1
#1 out of 1
business21h ago
Ozempic, Wegovy, Mounjaro: Affluent Indians use Western drugs to lose weight gained from Western habits
- Latest development shows Mounjaro gaining rapid uptake in India as a weight-loss option among affluent patients.
- The drugs, used to treat diabetes, have become India’s most valued medicine by monthly sales in October, signaling strong demand.
- Regulators have approved Ozempic and related drugs for diabetes in India, not obesity, affecting how clinicians frame use for weight loss.
- Doctors warn that lifestyle changes are crucial, though injections can seem easier for patients seeking rapid results.
- High monthly costs limit access to these drugs, with some patients spending over $100 monthly on alternatives like Rybelsus.
- Experts attribute rising diabetes and obesity in India to Western-style diets and urban lifestyles.
- Some patients report substantial weight loss, while doctors caution about long-term dependence on injections.
- Industry insiders anticipate generic competition after patent expiry.
- Medical professionals stress combining medications with lifestyle changes to sustain results.
- The article highlights the gap between diabetes treatment costs and affordability in India.
Vote 0